Efficacy, safety, and B-cell depletion capacity of three rituximab dosing regimens in the treatment of moderate-to-severe pemphigus vulgaris and pemphigus foliaceus: a 52-week clinical trial
收藏Mendeley Data2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/jd8hp2377n/1
下载链接
链接失效反馈官方服务：
资源简介：
Supplemental material for "Efficacy, safety, and B-cell depletion capacity of three rituximab dosing regimens in the treatment of moderate-to-severe pemphigus vulgaris and pemphigus foliaceus: a 52-week clinical trial".
提供机构：
Shandong Provincial Institute of Dermatology and Venereology
